Balchem [BCPC] vs Sherwin-Williams [SHW] Detailed Stock Comparison
Balchem
Sherwin-Williams
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Balchem wins in 8 metrics, Sherwin-Williams wins in 12 metrics, with 0 ties. Sherwin-Williams appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Balchem | Sherwin-Williams | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 32.38 | 33.46 | Balchem |
| Price-to-Book Ratio | 3.61 | 19.05 | Balchem |
| Debt-to-Equity Ratio | 16.38 | 308.57 | Balchem |
| PEG Ratio | 1.68 | -2.33 | Sherwin-Williams |
| EV/EBITDA | 19.42 | 22.55 | Balchem |
| Profit Margin (TTM) | 14.48% | 11.03% | Balchem |
| Operating Margin (TTM) | 20.30% | 17.46% | Balchem |
| EBITDA Margin (TTM) | 20.30% | 17.46% | Balchem |
| Return on Equity | 11.99% | 62.43% | Sherwin-Williams |
| Return on Assets (TTM) | 7.66% | 9.34% | Sherwin-Williams |
| Free Cash Flow (TTM) | $146.34M | $2.08B | Sherwin-Williams |
| Dividend Yield | 0.54% | 0.67% | Sherwin-Williams |
| 1-Year Return | -18.53% | -12.08% | Sherwin-Williams |
| Price-to-Sales Ratio (TTM) | 4.65 | 3.65 | Sherwin-Williams |
| Enterprise Value | $4.72B | $97.16B | Sherwin-Williams |
| EV/Revenue Ratio | 4.79 | 4.21 | Sherwin-Williams |
| Gross Profit Margin (TTM) | 36.45% | 49.38% | Sherwin-Williams |
| Revenue per Share (TTM) | $30 | $92 | Sherwin-Williams |
| Earnings per Share (Diluted) | $4.36 | $10.09 | Sherwin-Williams |
| Beta (Stock Volatility) | 0.92 | 1.20 | Balchem |
Balchem vs Sherwin-Williams Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Balchem | 3.09% | -4.07% | -11.47% | -13.68% | -12.11% | -11.53% |
| Sherwin-Williams | -0.12% | -3.11% | -7.79% | -5.21% | -0.90% | 0.02% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Balchem | -18.53% | 11.07% | 33.21% | 106.02% | 354.19% | 1,653.75% |
| Sherwin-Williams | -12.08% | 65.21% | 43.77% | 311.08% | 1,288.42% | 2,209.22% |
News Based Sentiment: Balchem vs Sherwin-Williams
Balchem
News based Sentiment: MIXED
Balchem experienced a mixed month, with positive Q2 earnings and an analyst upgrade countered by a 52-week low and bearish technical signals. This creates a complex investment picture, making October a significant month for the company's trajectory.
Sherwin-Williams
News based Sentiment: MIXED
October presented a mixed bag for Sherwin-Williams, with a large acquisition offset by disappointing earnings and cautious financial maneuvering. While the Suvinil deal offers long-term potential, near-term headwinds and mixed analyst sentiment create uncertainty, making it a significant but complex month for investors.
Performance & Financial Health Analysis: Balchem vs Sherwin-Williams
| Metric | BCPC | SHW |
|---|---|---|
| Market Information | ||
| Market Cap | $4.66B | $84.17B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 137,710 | 1,484,380 |
| 90 Day Avg. Volume | 154,037 | 1,696,370 |
| Last Close | $144.64 | $332.81 |
| 52 Week Range | $139.17 - $185.96 | $308.84 - $400.42 |
| % from 52W High | -22.22% | -16.88% |
| All-Time High | $186.03 (Jul 29, 2024) | $400.42 (Nov 25, 2024) |
| % from All-Time High | -22.25% | -16.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.01% |
| Quarterly Earnings Growth | 0.19% | -0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.11% |
| Operating Margin (TTM) | 0.20% | 0.17% |
| Return on Equity (TTM) | 0.12% | 0.62% |
| Debt to Equity (MRQ) | 16.38 | 308.57 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $39.07 | $17.72 |
| Cash per Share (MRQ) | $2.02 | $1.10 |
| Operating Cash Flow (TTM) | $187.33M | $3.06B |
| Levered Free Cash Flow (TTM) | $126.15M | $1.78B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.54% | 0.67% |
| Last 12-Month Dividend | $0.87 | $2.21 |
Valuation & Enterprise Metrics Analysis: Balchem vs Sherwin-Williams
| Metric | BCPC | SHW |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 32.38 | 33.46 |
| Forward P/E | 28.93 | 26.41 |
| PEG Ratio | 1.68 | -2.33 |
| Price to Sales (TTM) | 4.65 | 3.65 |
| Price to Book (MRQ) | 3.61 | 19.05 |
| Market Capitalization | ||
| Market Capitalization | $4.66B | $84.17B |
| Enterprise Value | $4.72B | $97.16B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.79 | 4.21 |
| Enterprise to EBITDA | 19.42 | 22.55 |
| Risk & Other Metrics | ||
| Beta | 0.92 | 1.20 |
| Book Value per Share (MRQ) | $39.07 | $17.72 |
Financial Statements Comparison: Balchem vs Sherwin-Williams
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BCPC | SHW |
|---|---|---|
| Revenue/Sales | $255.47M | $6.31B |
| Cost of Goods Sold | $162.35M | $3.20B |
| Gross Profit | $93.11M | $3.12B |
| Research & Development | $4.30M | N/A |
| Operating Income (EBIT) | $51.44M | $1.10B |
| EBITDA | $63.18M | $1.27B |
| Pre-Tax Income | $49.01M | $985.70M |
| Income Tax | $10.73M | $231.00M |
| Net Income (Profit) | $38.28M | $754.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BCPC | SHW |
|---|---|---|
| Cash & Equivalents | $49.90M | $269.80M |
| Total Current Assets | $340.24M | $6.43B |
| Total Current Liabilities | $139.56M | $8.20B |
| Long-Term Debt | $204.14M | $9.43B |
| Total Shareholders Equity | $1.21B | $4.40B |
| Retained Earnings | $1.03B | $8.11B |
| Property, Plant & Equipment | $340.80M | $2.01B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BCPC | SHW |
|---|---|---|
| Operating Cash Flow | $38.04M | $1.08B |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $30.90M | $931.10M |
| Debt Repayment | $-29.05M | $0 |
| Common Stock Repurchase | $-5.33M | $-518.50M |
Short Interest & Institutional Ownership Analysis
| Metric | BCPC | SHW |
|---|---|---|
| Shares Short | 425,613 | 4.31M |
| Short Ratio | 3.01 | 2.35 |
| Short % of Float | 0.02% | 0.02% |
| Average Daily Volume (10 Day) | 137,710 | 1,484,380 |
| Average Daily Volume (90 Day) | 154,037 | 1,696,370 |
| Shares Outstanding | 32.53M | 251.29M |
| Float Shares | 32.28M | 229.92M |
| % Held by Insiders | 0.00% | 0.07% |
| % Held by Institutions | 0.91% | 0.84% |
Dividend Analysis & Yield Comparison: Balchem vs Sherwin-Williams
| Metric | BCPC | SHW |
|---|---|---|
| Last 12-Month Dividend | $0.87 | $2.21 |
| Last 12-Month Dividend Yield | 0.54% | 0.67% |
| 3-Year Avg Annual Dividend | $0.79 | $2.21 |
| 3-Year Avg Dividend Yield | 0.55% | 0.23% |
| 3-Year Total Dividends | $2.37 | $6.63 |
| Ex-Dividend Date | Dec 26, 2024 | Mar 03, 2025 |